Loading clinical trials...
Loading clinical trials...
Single-arm, Prospective, Multicenter Clinical Trial to Assess the Efficacy and the Safety of Combination Therapy of Hepatic Arterial Infusion of Cisplatin and 5-FU in Advanced Hepatocellular Carcinoma With Low Expression of HMGB2 Biomarker
Conditions
Interventions
cisplatin and 5-fluorouracil
Locations
12
South Korea
Korea University Ansan Hospital
Ansan, South Korea
Sooncheonhyang University Hospital Bucheon
Bucheon-si, South Korea
The Catholic University of Korea Bucheon ST. Mary's Hospital
Bucheon-si, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
The Catholic University of Korea Daejeon ST. Mary's Hospital
Daejeon, South Korea
Chonnam National University Hwasun Hospital
Hwasun, South Korea
Start Date
November 1, 2016
Primary Completion Date
October 1, 2018
Completion Date
December 1, 2018
Last Updated
July 17, 2017
NCT06707233
NCT05911633
NCT06187961
NCT06561399
NCT04224636
NCT06397222
Lead Sponsor
CbsBioscience
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions